Company intelligence / Profile preview

HM Venture Partners

San Francisco, California, United Stateshmventurepartners.com ↗

Ownership: Private
Development stage: Other

Overview

HM Venture Partners is a healthcare venture capital firm founded in 2019 that manages over $600M across three funds and invests globally in high-growth biotech and medtech companies at all stages. The team has deep domain expertise and has established joint ventures such as HM Healthcare Management Services with Hillhouse Investment Group and Mayo Clinic. Their investments have led to significant collaborations such as BioNTech/OncoC4 for novel checkpoint antibodies targeting solid tumors.

Therapeutic areas: OncologyPulmonology
Modalities: Small moleculeMonoclonal antibodyDeviceDrug coated balloon technology
Industry: Investors

Partnerships

Hillhouse Investment Group (joint venture)Mayo Clinic (joint venture)BioNTech/OncoC4 collaboration (portfolio company partnership)

Beyond the preview

Go deeper on HM Venture Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HM Venture Partners.

Explore the full profile